<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Aguilan JT</submitter><funding>NICHD NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Jansen de Vries Syndrome (JdVS) is a rare neurodevelopmental disorder (NDD) caused by gain-of-function (GOF) truncating mutations in &lt;i>PPM1D&lt;/i> exons 5 or 6. PPM1D is a serine/threonine phosphatase that plays an important role in the DNA damage response (DDR) by negatively regulating TP53 (P53). JdVS-associated mutations lead to the formation of a truncated PPM1D protein that retains catalytic activity and has a GOF effect because of reduced degradation. Somatic &lt;i>PPM1D&lt;/i> exons 5 and 6 truncating mutations are well-established factors in a number of cancers, due to excessive dephosphorylation and reduced function of P53 and other substrates involved in DDR. Children with JdVS have a variety of neurodevelopmental, psychiatric, and physical problems. In addition, a sm</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2023.07.08.548192</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10350077</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Proteomics and phosphoproteomics profiling in glutamatergic neurons and microglia in an iPSC model of Jansen de Vries Syndrome.</pubmed_title><pmcid>PMC10350077</pmcid><funding_grant_id>R21 MH131740</funding_grant_id><funding_grant_id>P30 CA013330</funding_grant_id><funding_grant_id>S10 OD030286</funding_grant_id><funding_grant_id>P30 HD071593</funding_grant_id><funding_grant_id>S10 OD026833</funding_grant_id><pubmed_authors>Aguilan JT</pubmed_authors><pubmed_authors>Baykara RN</pubmed_authors><pubmed_authors>Sidoli S</pubmed_authors><pubmed_authors>Barnes J</pubmed_authors><pubmed_authors>Lachman HM</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Pedrosa E</pubmed_authors><pubmed_authors>Dolstra H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proteomics and phosphoproteomics profiling in glutamatergic neurons and microglia in an iPSC model of Jansen de Vries Syndrome.</name><description>&lt;h4>Background&lt;/h4>Jansen de Vries Syndrome (JdVS) is a rare neurodevelopmental disorder (NDD) caused by gain-of-function (GOF) truncating mutations in &lt;i>PPM1D&lt;/i> exons 5 or 6. PPM1D is a serine/threonine phosphatase that plays an important role in the DNA damage response (DDR) by negatively regulating TP53 (P53). JdVS-associated mutations lead to the formation of a truncated PPM1D protein that retains catalytic activity and has a GOF effect because of reduced degradation. Somatic &lt;i>PPM1D&lt;/i> exons 5 and 6 truncating mutations are well-established factors in a number of cancers, due to excessive dephosphorylation and reduced function of P53 and other substrates involved in DDR. Children with JdVS have a variety of neurodevelopmental, psychiatric, and physical problems. In addition, a sm</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2026-05-25T03:08:41.06Z</modification><creation>2026-05-25T03:07:32.572Z</creation></dates><accession>S-EPMC10350077</accession><cross_references><pubmed>37461463</pubmed><doi>10.1101/2023.07.08.548192</doi></cross_references></HashMap>